Role of IL-6 and neopterin in the pathogenesis of herpetic encephalitis

Pharmacological Reports

Volumn 63, Issue 5, 2011, Pages 1203-1209

  Bocia̧ga Jasik, Monika ^a   Cieśla, Andrzej ^a   Kalinowska Nowak, Anna ^a   Skwara, Paweł ^a   Garlicki, Aleksander ^a   Mach, Tomasz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Complications; Herpetic encephalitis; IL 6; Neopterin; Pathogenesis; Prognosis

Indexed keywords

INTERLEUKIN 6; NEOPTERIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CAUSE OF DEATH; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GLASGOW COMA SCALE; HERPES SIMPLEX ENCEPHALITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; NEUROLOGICAL COMPLICATION; OUTCOME ASSESSMENT; PREDICTION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RESPIRATORY FAILURE; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

EID: 83155192327     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/s1734-1140(11)70640-5     Document Type: Article

References (21)

1. Armien AG, Hu S, Little MR, Robinson N, Lokensgard JR, Low WC, Cheeran MC: Chronic cortical and subcortical pathology with associated neurological deficits ensuing experimental herpes encephalitis. Brain Pathol, 2010, 20, 738-750.
2. Asaoka K, Shoji H, Nishizaka S, Ayabe M, Abe T, Ohori N, Ichiyama T, Eizuru Y: Non-herpetic acute limbic encephalitis: cerebrospinal fluid cytokines and magnetic resonance imaging findings. Intern Med, 2004, 43, 42-48. (Pubitemid 38208374)
3. Aurelius E, Forsgren M, Skoldenberg B, Strannegard O: Persistent intrathecal immune activation in patients with herpes simplex encephalitis. J Infect Dis, 1993, 168, 1248-1252. (Pubitemid 23317143)
4. Azumagawa K, Suzuki S, Tanabe T, Wakamiya E, Kawamura N, Tamai H: Neopterin, biopterin, and nitric oxide concentrations in the cerebrospinal fluid of children with central nervous system infections. Brain Dev, 2003, 25, 200-202. (Pubitemid 36407527)
5. Berdowska A Zwirska-Korczala K: Neopterin measurement in clinical diagnosis. J Clin Pharm Ther, 2001, 26, 319-329.
6. Conrady CD, Drevets DA, Carr DJ: Herpes simplex type I (HSV-1) infection of the nervous system: Is an immune response a good thing? J Neuroimmunol, 2010, 220, 1-9.
7. Dvorak F, Martinez-Torres F, Sellner J, Haas J, Schellinger PD, Schwaninger M, Meyding-Lamade UK: Experimental herpes simplex virus encephalitis: a long-term study of interleukin-6 expression in mouse brain tissue. Neurosci Lett, 2004, 367, 289-292. (Pubitemid 39178598)
8. Ichiyama T, Shoji H, Takahashi Y, Matsushige T, Kajimoto M, Inuzuka T, Furukawa S: Cerebrospinal fluid levels of cytokines in non-herpetic acute limbic encephalitis: comparison with herpes simplex encephalitis. Cytokine, 2008, 44, 149-153.
9. Kamei S, Taira N, Ishihara M, Sekizawa T, Morita A, Miki K, Shiota H et al.: Prognostic value of cerebrospinal fluid cytokine changes in herpes simplex virus encephalitis. Cytokine, 2009, 46, 187-193.
10. Lokensgard JR, Cheeran MC, Hu S, Gekker G, Peterson PK: Glial cell responses to herpesvirus infections: role in defense and immunopathogenesis. J Infect Dis, 2002, 186 2, 171-179.
11. Lundberg P, Ramakrishna C, Brown J, Tyszka JM, Hamamura M, Hinton DR, Kovats S et al.: The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis. J Virol, 2008, 82, 7078-7088. (Pubitemid 351977726)
12. Marques CP, Cheeran MC, Palmquist JM, Hu S, Urban SL, Lokensgard JR: Prolonged microglial cell activation and lymphocyte infiltration following experimental herpes encephalitis. J Immunol, 2008, 181, 6417-6426.
13. Martinez-Torres F, Menon S, Pritsch M, Victor N, Jenetzky E, Jensen K, Schielke E et al.: Protocol for German trial of acyclovir and corticosteroids in herpes-simplex- virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933]. BMC Neurol, 2008, 8, 40.
14. Riera-Mestre A, Gubieras L, Martinez-Yelamos S, Cabellos C, Fernandez-Viladrich P: Adult herpes simplex encephalitis: fifteen years' experience. Enferm Infecc Microbiol Clin, 2009, 27, 143-147.
15. Schachtele SJ, Hu S, Little MR, Lokensgard JR: Herpes simplex virus induces neural oxidative damage via microglial cell Toll-like receptor-2. J Neuroinflammation, 2010, 7, 35.
16. Sergerie Y, Boivin G, Gosselin D, Rivest S: Delayed but not early glucocorticoid treatment protects the host during experimental herpes simplex virus encephalitis in mice. J Infect Dis, 2007, 195, 817-825. (Pubitemid 46363926)
17. Skoldenberg B, Aurelius E, Hjalmarsson A, Sabri F, Forsgren M, Andersson B, Linde A et al.: Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults. J Neurol, 2006, 253, 163-170. (Pubitemid 43255885)
18. Taira N, Kamei S, Morita A, Ishihara M, Miki K, Shiota H, Mizutani T: Predictors of a prolonged clinical course in adult patients with herpes simplex virus encephalitis. Intern Med, 2009, 48, 89-94.
19. Vilela MC, Mansur DS, Lacerda-Queiroz N, Rodrigues DH, Lima GK, Arantes RM, Kroon EG et al.: The chemokine CCL5 is essential for leukocyte recruitment in a model of severe herpes simplex encephalitis. Ann NY Acad Sci, 2009, 1153, 256-263.
20. Whitley RJ: Herpes simplex encephalitis: adolescents and adults. Antiviral Res, 2006, 71, 141-148.
21. Wilson SS, Fakioglu E, Herold BC: Novel approaches in fighting herpes simplex virus infections. Expert Rev Anti Infect Ther, 2009, 7, 559-568.